NEOS Neos Therapeutics Inc.

Drug Information

Drug catalyst information is displayed when you hover over / tap on the stage bar graph.

Latest News

1. 13 March 2020 Neos Therapeutics Reports Fourth Quarter and Year-End 2019 Financial Results

   – Full year 2019 net revenues increased by 29% and operating loss decreased by $33M – – Neos RxConnect rapidly expanded with ~500 pharmacies in network at year-end – – NT0502 Phase 1 ascending dose trial

2. 06 March 2020 Neos Therapeutics to Host Fourth Quarter and Year-End 2019 Financial and Operating Results Conference Call on March 13th, 2020

   DALLAS and FORT WORTH, Texas, March 06, 2020 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a commercial-stage pharmaceutical company developing and manufacturing central nervous system-focused products,

3. 26 February 2020 Neos Therapeutics to Present at the Cowen & Co. 40th Annual Health Care Conference

   DALLAS and FORT WORTH, Texas, Feb. 26, 2020 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a commercial-stage pharmaceutical company developing and manufacturing central nervous system-focused products,

4. 13 January 2020 Neos Therapeutics Initiates and Completes Dosing in a Phase 1 Trial of NT0502 for the Treatment of Chronic Sialorrhea

   DALLAS and FORT WORTH, Texas, Jan. 13, 2020 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a commercial-stage pharmaceutical company developing and manufacturing central nervous system-focused products,

5. 08 November 2019 Neos Therapeutics Reports Third Quarter 2019 Financial Results

   DALLAS and FORT WORTH, Texas, Nov. 08, 2019 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a commercial-stage pharmaceutical company utilizing its novel microparticle delivery technology to develop and

6. 01 November 2019 Neos Therapeutics to Host Third Quarter 2019 Financial and Operating Results Conference Call on November 8, 2019

   DALLAS and FORT WORTH, Texas, Nov. 01, 2019 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a commercial-stage pharmaceutical company utilizing its novel microparticle delivery technology to develop and

7. 25 September 2019 Neos Therapeutics to Present at Cantor Fitzgerald Global Healthcare Conference

   DALLAS and FORT WORTH, Texas, Sept. 25, 2019 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a commercial-stage pharmaceutical company utilizing its novel microparticle delivery technology to develop and

8. 29 August 2019 Neos Therapeutics to Present at Two Upcoming September Conferences

   DALLAS and FORT WORTH, Texas, Aug. 29, 2019 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a commercial-stage pharmaceutical company utilizing its novel microparticle delivery technology to develop and